These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7019328)

  • 1. Effects of IgG and IgM alloantibodies in the enhancement of mouse skin allografts and the relation with their opsonizing capacity in vivo.
    Lems SP; Tamboer WP; Capel PJ; Koene RA
    J Immunol; 1981 Aug; 127(2):665-9. PubMed ID: 7019328
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of decomplementation with cobra venom factor on the passive immunological enhancement of mouse skin allografts.
    Hutchinson IV; Brent L
    Transplantation; 1982 Jul; 34(1):64-7. PubMed ID: 6750879
    [No Abstract]   [Full Text] [Related]  

  • 4. Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.
    Capel PJ; Tamboer WP; de Waal RM; Jansen JL; Koene RA
    J Immunol; 1979 Feb; 122(2):421-5. PubMed ID: 368240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune regulation by monoclonal antibodies: failure to enhance mouse skin allografts.
    Lems SP; Tax WJ; Capel PJ; Koene RA
    J Immunol; 1983 Jul; 131(1):86-91. PubMed ID: 6345667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-reactive lymphocytes are opsonized in mice with passively enhanced skin allografts but not in tolerant mice.
    Hutchinson IV; Rayfield LS; Brent L
    Transplantation; 1982 Feb; 33(2):204-6. PubMed ID: 7036475
    [No Abstract]   [Full Text] [Related]  

  • 8. Similar activities of IgG1 and IgG2 alloantibodies in enhancement of mouse skin grafts and in opsonization.
    Lems SP; Rijke-Schilder TP; Capel PJ; Koene RA
    Transplantation; 1984 Mar; 37(3):291-6. PubMed ID: 6701959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of chimerism in maintaining tolerance of skin allografts in mice.
    Lubaroff DM; Silvers WK
    J Immunol; 1973 Jul; 111(1):65-71. PubMed ID: 4576586
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response and skin graft rejection in the nude mouse.
    Gerlag PG; Capel PJ; Berden JH; Koene RA
    Transplant Proc; 1977 Mar; 9(1):1179-82. PubMed ID: 325744
    [No Abstract]   [Full Text] [Related]  

  • 11. Passive enhancement of mouse tumor allografts by alloantibodies is Fc-dependent.
    de Waal RM; Cornelissen IM; Capel PJ; Koene RA
    J Immunol; 1979 Sep; 123(3):1353-5. PubMed ID: 469254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologicc activity of the aged.
    Makinodan T; Perkins EH; Chen MG
    Adv Gerontol Res; 1971; 3():171-98. PubMed ID: 4398644
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding in vivo of enhancing antibodies to skin allografts and specific allogeneic tissues.
    Jones JM; Peter HH; Feldman JD
    J Immunol; 1972 Feb; 108(2):301-9. PubMed ID: 4558862
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloantibodies in relation to the rejection of skin allografts in the mouse.
    Harris TN; Harris S
    Adv Exp Med Biol; 1976; 73 Pt B():253-67. PubMed ID: 793335
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.
    Koene RA; Gerlag PG; Hagemann JF; van Haelst UJ; Wijdeveld PG
    J Immunol; 1973 Aug; 111(2):520-6. PubMed ID: 4577882
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial specific unresponsiveness to second-set allografts following chronic rejection of first-set allografts.
    Végh P; Jánossy T; Erdös E; Petri G; Kováta TG
    Transplantation; 1976 Sep; 22(3):303-5. PubMed ID: 788255
    [No Abstract]   [Full Text] [Related]  

  • 18. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
    J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
    Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
    Thai NL; Fu F; Qian S; Sun H; Gao L; Wang SC; Demetris AJ; Woo J; Thomson AW; Duquesnoy RJ
    Transplantation; 1995 Jan; 59(2):274-81. PubMed ID: 7530874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.